Influenza prevention 2002-2003.
D000081:Acetamides / Q000009:adverse effects / Q000627:therapeutic use; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006146:Guanidines; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007251:Influenza, Human / Q000517:prevention & control*; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D053139:Oseltamivir; D011247:Pregnancy; D011714:Pyrans; D012794:Sialic Acids / Q000009:adverse effects / Q000627:therapeutic use; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D006146:Guanidines; D007252:Influenza Vaccines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir